Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).

The phospholipid scramblases (PLSCR1 to PLSCR4) are a structurally and functionally unique class of proteins, which are products of a tetrad of genes conserved from Caenorhabditis elegans to humans. The best characterized member of this family, PLSCR1, is implicated in the remodeling of the transbilayer distribution of plasma membrane phospholipids but is also required for normal signaling through select growth factor receptors. Mice with targeted deletion of PLSCR1 display perinatal granulocytopenia due to defective response of hematopoietic precursors to granulocyte colony-stimulating factor and stem cell factor. To gain insight into the biologic function of another member of the PLSCR family, we investigated mice with targeted deletion of PLSCR3, a protein that like PLSCR1 is expressed in many blood cells but which, by contrast to PLSCR1, is also highly expressed in fat and muscle. PLSCR3(-/-) mice at 2 months of age displayed aberrant accumulation of abdominal fat when maintained on standard rodent chow, which was accompanied by insulin resistance, glucose intolerance, and dyslipidemia. Primary adipocytes and cultured bone-marrow-derived macrophages from PLSCR3(-/-) mice were engorged with neutral lipid, and adipocytes displayed defective responses to exogenous insulin. Plasma of PLSCR3(-/-) mice was elevated in non-high-density lipoproteins, cholesterol, triglycerides, nonesterified fatty acids, and leptin, whereas adiponectin was low. These data suggest that the expression of PLSCR3 may be required for normal adipocyte and/or macrophage maturation or function and raise the possibility that deletions or mutations affecting the PLSCR3(-/-) gene locus may contribute to the risk for lipid-related disorders in humans.

[1]  R. N. Harty,et al.  Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon , 2004, Journal of Virology.

[2]  M. Fessler,et al.  Phospholipid Flip-Flop and Phospholipid Scramblase 1 (PLSCR1) Co-localize to Uropod Rafts in Formylated Met-Leu-Phe-stimulated Neutrophils* , 2004, Journal of Biological Chemistry.

[3]  L. Gerace,et al.  Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. , 2004, Biochemistry.

[4]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[5]  E. Van Obberghen,et al.  Molecular mechanisms of insulin receptor substrate protein‐mediated modulation of insulin signalling , 2003, FEBS letters.

[6]  P. Sims,et al.  Palmitoylation of phospholipid scramblase 1 controls its distribution between nucleus and plasma membrane. , 2003, Biochemistry.

[7]  D. Daleke.  Regulation of transbilayer plasma membrane phospholipid asymmetry Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.R200019-JLR200 , 2003, Journal of Lipid Research.

[8]  P. Williamson,et al.  Transbilayer phospholipid movement and the clearance of apoptotic cells. , 2002, Biochimica et biophysica acta.

[9]  M. Benhamou,et al.  Phospholipid scramblase, a new effector of FcεRI signaling in mast cells , 2002 .

[10]  Johan W M Heemskerk,et al.  Platelet Activation and Blood Coagulation , 2002, Thrombosis and Haemostasis.

[11]  P. Sims,et al.  Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. , 2002, Blood.

[12]  P. Sims,et al.  Plasma membrane phospholipid scramblase 1 is enriched in lipid rafts and interacts with the epidermal growth factor receptor. , 2002, Biochemistry.

[13]  S. Tomoyasu,et al.  Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes. , 2002, Experimental hematology.

[14]  R. Gambino,et al.  Plasma homocysteine, methylenetetrahydrofolate reductase gene polymorphism and carotid intima‐media thickness in Italian type 2 diabetic patients , 2002, European journal of clinical investigation.

[15]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[16]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[17]  D. Moller,et al.  New drug targets for type 2 diabetes and the metabolic syndrome , 2001, Nature.

[18]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[19]  J. Flier,et al.  A Transgenic Model of Visceral Obesity and the Metabolic Syndrome , 2001, Science.

[20]  M. Schwartz,et al.  c-Abl Tyrosine Kinase Binds and Phosphorylates Phospholipid Scramblase 1* , 2001, The Journal of Biological Chemistry.

[21]  P. Williamson,et al.  Phospholipid scramblase activation pathways in lymphocytes. , 2001, Biochemistry.

[22]  P. Sims,et al.  Unraveling the Mysteries of Phospholipid Scrambling , 2001, Thrombosis and Haemostasis.

[23]  Dan Zhu,et al.  Role of a JAK3-dependent Biochemical Signaling Pathway in Platelet Activation and Aggregation* , 2001, The Journal of Biological Chemistry.

[24]  R. Bergman,et al.  Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus , 2000, Trends in Endocrinology & Metabolism.

[25]  C. Bogardus,et al.  Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance , 2000, Diabetologia.

[26]  P. Sims,et al.  Identification of three new members of the phospholipid scramblase gene family. , 2000, Biochimica et biophysica acta.

[27]  Y. Tyurina,et al.  Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis , 2000, FEBS letters.

[28]  S. O’Rahilly,et al.  The perils of portliness: causes and consequences of visceral adiposity. , 2000, Diabetes.

[29]  V. Fadok,et al.  Regulation of Phospholipid Scramblase Activity during Apoptosis and Cell Activation by Protein Kinase Cδ* , 2000, The Journal of Biological Chemistry.

[30]  R. Silverman,et al.  Transcriptional control of the human plasma membranephospholipid scramblase 1 gene is mediated by interferon-α , 2000 .

[31]  Ronald W. Davis,et al.  Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. , 1999, Science.

[32]  L. Curtiss,et al.  ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[34]  Y. Honma,et al.  Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene. , 1998, Biochemical and biophysical research communications.

[35]  P. Sims,et al.  Level of Expression of Phospholipid Scramblase Regulates Induced Movement of Phosphatidylserine to the Cell Surface* , 1998, The Journal of Biological Chemistry.

[36]  P. Sims,et al.  Molecular Cloning of Human Plasma Membrane Phospholipid Scramblase , 1997, The Journal of Biological Chemistry.

[37]  Y. Honma,et al.  TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines. , 1997, Blood.